CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net revenue	$ 804,031	$ 756,495	$ 2,341,943	$ 2,190,312
Revenue, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
Costs and expenses:
Cost of net revenue	$ 693,488	$ 646,714	$ 2,022,281	$ 1,853,847
Cost, Product and Service [Extensible Enumeration]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]	Health Care, Patient Service [Member]
General and administrative expenses	$ 45,198	$ 40,681	$ 142,797	$ 124,673
Depreciation and amortization, excluding patient equipment depreciation	14,515	16,151	45,596	48,113
Goodwill impairment (note 5)	511,866	0	511,866	0
Total costs and expenses	1,265,067	703,546	2,722,540	2,026,633
Operating (loss) income	(461,036)	52,949	(380,597)	163,679
Interest expense, net	32,306	28,521	96,813	78,905
Change in fair value of warrant liability (note 10)	(9,160)	1,364	(31,886)	(17,145)
Other loss, net	3,317	257	6,574	7,179
(Loss) income before income taxes	(487,499)	22,807	(452,098)	94,740
Income tax (benefit) expense	(34,578)	5,580	(30,893)	20,036
Net (loss) income	(452,921)	17,227	(421,205)	74,704
Income attributable to noncontrolling interest	1,155	1,105	3,187	2,800
Net (loss) income attributable to AdaptHealth Corp.	$ (454,076)	$ 16,122	$ (424,392)	$ 71,904
Weighted average common shares outstanding - basic (in shares)	134,825	134,227	134,549	134,186
Weighted average common shares outstanding - diluted (in shares)	134,982	137,583	135,202	138,599
Basic net income (loss) per share (note 11) (in dollars per share)	$ (3.37)	$ 0.11	$ (3.15)	$ 0.49
Diluted net income (loss) per share (note 11) (in dollars per share)	$ (3.43)	$ 0.11	$ (3.37)	$ 0.35